Clearside Biomedical, Inc. — Director's Dealing 2019

Jun 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2019-06-20

Reporting Person: Humphries William D. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-20	Stock Option (right to buy)	$1.07	A	20000	Acquired	2029-06-19	Common Stock (20000)	Direct

Footnotes

F1: The shares underlying this option vest in full on the earlier of the Issuer's next meeting of stockholders or June 20, 2020.